CONTINUE TO SITE ➞

Don't miss tomorrow's biopharma industry news

Let BioPharma Dive's free newsletter keep you informed, straight from your inbox.

Daily Dive M-F

Commercialization Weekly Every Wednesday

Gene Therapy Weekly Every Thursday

Emerging Biotech Weekly Every Tuesday

By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

Deep Dive
Library
Events
Press Releases

Pharma
Biotech
FDA
Clinical Trials
Deals
Drug Pricing
Gene Therapy

What We're Reading: Page 212

Industry reads hand-picked by our editors

Aug 08, 2019

OneZero
Should You Save Your Cells Now to Fight Cancer Later?
GeekWire
'Mega Block' in Amazon’s backyard will become a life sciences campus following $143.5M deal
Forbes
Scientists' Credibility Crucial To Biopharma's Reputation

Aug 07, 2019

Axios
Wall Street fears opioids settlement for big drug distributors could be large
CNBC
Amazon's PillPack expansion faces resistance from CVS and Walgreens
S&P Global
US cost watchdog proposes framework changes to address cell, gene therapy prices

Aug 06, 2019

Bloomberg
Opioid Distributors Propose $10 Billion to End State Claims
Roll Call
Senate bill’s drug pricing provision raises industry alarms
Kaiser Health News
Drugmakers Master Rolling Out Their Own Generics To Stifle Competition

Aug 05, 2019

Reuters
Drug industry urges Canada to act early on U.S. import plan
The New York Times
Tainted Pork, Ill Consumers and an Investigation Thwarted
BioCentury
Bringing CAR T to India
STAT
Blood test could replace biopsy for rare cancer treated by Keytruda

Aug 02, 2019

The New York Times
A blood test for Alzheimer's? It's coming, scientists report
STAT
Pharma lawsuit against California transparency law can proceed
The Wall Street Journal
U.S. drug epidemic becoming more urban
BioSpace
Boston's Vida Ventures snags $600 million for new life science fund

Aug 01, 2019

Bloomberg
Trump’s 'Crazy' Drug Import Plan Stirs Supply Fears in Canada
Reuters
Oklahoma makes final bid to hold J&J responsible for opioid epidemic
The New York Times
Democratic Debate Turns Ferocious Over Health Care

Jul 31, 2019

C&EN
Genentech's R&D chief Michael Varney on the future of drug discovery
Axios
The monopolization of patient drug data
Endpoints News
Bayer, Orion win speedy approval for prostate cancer drug darolutamide

Previous Next

Get the free newsletter

Subscribe to BioPharma Dive for top news, trends & analysis

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.

Library resources

Industry Report
CGT Commercialization: Tackling Barriers to Market Success Custom content for Cencora
Playbook
Centralized Clinical Trial Recruitment: A Strategic Plan Custom content for WCG
Trendline
Inside the growing treatment market for rare diseases Supported by Advanced Clinical

View all

Company Announcements

View all | Post a press release

Events

View all | Promote an event

Industry Intel

Top Ways that AI Will Change Life Sciences Webinar - on demand • Provided by Salesforce
Trends and Innovations in Life Science Qualitative Research Webinar - on demand • Provided by Konovo
Evolving Regulatory Landscape for Model Informed Drug Development (MIDD): Impact of the Draft ICH M15 Guidance Webinar - on demand • Provided by Certara

Explore

About
Editorial Team
Contact Us
Newsletter
Purchase Licensing Rights
Press Releases
What We're Reading

Reach our audience

Advertising
Post a press release
Promote an event

Related Publications

Healthcare Dive
MedTech Dive

Industry Dive is an Informa TechTarget business.

This website is owned and operated by Informa TechTarget, part of a global network that informs, influences and connects the world's technology buyers and sellers. All copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. TechTarget, Inc.'s registered office is 275 Grove St. Newton, MA 02466.

Home
- Pharma
- Biotech
- FDA
- Clinical Trials
- Deals
- Drug Pricing
- Gene Therapy
Deep Dive
Library
Events
Press Releases

Get BioPharma Dive in your inbox

The free newsletter covering the top industry headlines

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.